CA-QUANTA-CLOUD-TECH
26.8.2021 15:02:11 CEST | Business Wire | Press release
Quanta Cloud Technology (QCT), a leading data center hardware solution provider, today announced details around its participation at the Big 5G Event 2021 , being held onsite as well as virtually from August 30 – September 3, at the Colorado Convention Center, Denver. QCT will showcase 5G demos and solutions developed alongside ecosystem partners (Intel, Red Hat, Robin.io, Wind River, DZS) at Booth #900a for both public and private networks and share their latest insights at the event.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210826005348/en/
QCT 5G Demos, Solutions, and Partner Highlights at the Big 5G Event:
QCT 5G solutions span data center and edge, to on-premise, with two major product lines, IronInfra and OmniPOD , to address infrastructure modernization and digital transformation needs.
-
IronInfra Product Line
: QCT provides IronCloud and IronEdge solutions for telecom infrastructures.
-
IronCloud - Network Function Virtualization Infrastructure (NFVI) solutions for telecom operators. QCT IronCloud provides cloud native infrastructures for mobile network operators running 5G core, vRAN, CNFs, and CDN use cases through its ecosystem partnerships.
-
IronEdge - QCT’s edge solutions that have been approved by the Telecom Infra Project for building and supporting Open RAN in different scenarios, including Centralized RAN, Distributed RAN and MEC use cases.
-
-
OmniPOD Product Line
: End-to-end enterprise 5G network solutions that help achieve the realization of dynamic 5G applications and services.
-
OmniCore : QCT’s cloud-native, virtualized 5G core network solution that features high-availability designs to meet reliability demands and allows for the optimization of network functions.
-
OmniRAN : QCT’s 5G RAN solution consisting of BBU, FHGW, and RRU with flexible system configurations to fulfill diverse coverage and capacity needs.
-
OmniView : QCT’s Operations Administration and Management (OAM) system to manage and monitor OmniCore and OmniRAN.
-
-
Ecosystem Partner Highlights
: Developments alongside the following partners will be on-hand.
-
Intel/Red Hat : QCT builds an Open RAN CU/DU with Red Hat OpenShift, Intel FlexRAN and OpenNESS operator. It achieves automation of installation and configuration and allows easy resource management and monitoring for operators.
-
Robin.io : QCT and Robin.io developed an open and extensible cloud-native automation platform for deployment and lifecycle management of the entire 5G stack, both VNF and CNF with industry leading TCO.
-
Wind River : As a first wave partner to the Wind River Studio Hardware Ready Program, QCT completed self-validation with data center and edge servers which benefit service providers in quickly reducing OPEX while accelerating the introduction of new high-value services.
-
DZS : The QCT and DZS Converged Edge Cloud Blueprints provide simple, easy-to-deploy, jointly validated reference configurations of hardware and software for 5G network services and deployments across the Core, RAN, and Edge Access domains.
-
QCT experts will be available at Booth #900a to share their 5G journey and deployments for multiple customer POCs across industry verticals such as manufacturing, agriculture, and entertainment. Learn more at: https://go.qct.io/telco/
About Quanta Cloud Technology (QCT)
Quanta Cloud Technology (QCT) is a global data center solution provider that combines the efficiency of hyperscale hardware with infrastructure software from a diversity of industry leaders to solve next-generation data center design and operational challenges. QCT serves cloud service providers, telecoms and enterprises running public, hybrid and private clouds.
Product lines include hyperconverged and software-defined data center solutions as well as servers, storage, switches and integrated racks with an ecosystem of hardware components and software partners. QCT designs, manufactures, integrates and services its offerings via its own global network. The parent of QCT is Quanta Computer, Inc., a Fortune Global 500 corporation. www.QCT.io
View source version on businesswire.com: https://www.businesswire.com/news/home/20210826005348/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom